)
)
Syros Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Syros Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Syros Pharmaceuticals Inc
Access all reports
Syros Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. With its proprietary platform technology, Syros is developing an innovative pipeline of small molecule drugs designed to act at the level of the genome to promote cell survival, block disease activity and restore healthy homeostasis in patients.The company have indentified several drug targets in cancer and metabolic diseases, including disease-causing genes methyltransferases and histone acetyltransferases (HATs), as well as drivers of master oncogenic pathways such as PI3K and MEK.
Key slides for Syros Pharmaceuticals Inc
Corporate Presentation
Syros Pharmaceuticals Inc
Status Update
Syros Pharmaceuticals Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
SYRS
Country
🇺🇸 United States